Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Ileus laxative trial after colorectal surgery
ACTRN12618001261202Phase 4Recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Aug 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of docusate sodium + senna, polyethylene glycol and sodium phosphate in postoperative ileus (POI) (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoint: Time until return of gastrointestinal function (GI2). Started Aug 2018; status: recruiting.
02
Drugs
docusate sodium + sennapolyethylene glycolsodium phosphate
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ACTRN12618001261202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001261202.